In a study implemented in 2015, carbenoxolone showed its anti-apoptotic activities via PI3K/Akt pathways and suppressing the caspase-3 apoptosis pathway in rats exposed to transient focal ischemia and reperfusion (I/R) (Zhang et al. 2013). The gene discussed is AKT1; the disease is ischemia.